Inventor · disambiguated record
Tatsuyoshi Tanaka
Also filed as: TANAKA TATSUYOSHI
24 granted patents·13 pending applications·251 citations·filing 1980–2020
96Inventor score
Top patents by PatentIndex Score
37 records- 0197US7888362B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Feb 15, 2011·22 cites·9 claims
- 0292US8349840B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2010·Granted Jan 8, 2013·11 cites·6 claims
- 0391US4564619ACarbostyril derivativeOTSUKA PHARMA CO LTD·Filed 1983·Granted Jan 14, 1986·26 cites·26 claims
- 0490US8618109B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2012·Granted Dec 31, 2013·8 cites·3 claims
- 0586US9480686B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2015·Granted Nov 1, 2016·3 cites·4 claims
- 0685US9839637B1Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2017·Granted Dec 12, 2017·2 cites·18 claims
- 0784US9206167B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2013·Granted Dec 8, 2015·3 cites·4 claims
- 0884US8071600B2Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disordersYAMASHITA HIROSHI·Filed 2006·Granted Dec 6, 2011·7 cites·14 claims
- 0984US5053548ABiphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the compositionOTSUKA PHARMA CO LTD·Filed 1990·Granted Oct 1, 1991·63 cites·16 claims
- 1078US5786367ACyclic amide derivativesOTSUKA PHARMA CO LTD·Filed 1995·Granted Jul 28, 1998·29 cites·23 claims
- 1177US5137889ADihydropyridine derivatives and process for preparing the sameOTSUKA PHARMA CO LTD·Filed 1991·Granted Aug 11, 1992·16 cites·85 claims
- 1277US2021113556A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1376US8207370B2Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid esterHONDA TATSUYA·Filed 2007·Granted Jun 26, 2012·1 cites·15 claims
- 1475US5034395ANovel dihydropyridine derivativesOTSUKA PHARMA CO LTD·Filed 1987·Granted Jul 23, 1991·20 cites·7 claims
- 1574US2020237755A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1673US2019321359A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1772US2019117648A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1871US4435404ACarbostyril derivativesOTSUKA PHARMA CO LTD·Filed 1980·Granted Mar 6, 1984·12 cites·27 claims
- 1969US2018214444A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2067US5942641AFluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agentOTSUKA PHARMA CO LTD·Filed 1994·Granted Aug 24, 1999·13 cites·33 claims
- 2167US2017231983A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2266USRE48059EPiperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Jun 23, 2020·0 cites·15 claims
- 2365US8436196B2Type I natural ceramide derivative and method for producing sameTANAKA TATSUYOSHI·Filed 2009·Granted May 7, 2013·0 cites·20 claims
- 2465US2017000786A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 2555US12042540B2Formulation comprising active pharmaceutical ingredientKANEKA CORP·Filed 2019·Granted Jul 23, 2024·0 cites·13 claims
- 2650US7223859B2Method for producing (R)-3-[4-(trifluoromethyl) phenylamino]-pentanoic acid amide derivativePFIZER·Filed 2004·Granted May 29, 2007·0 cites·4 claims
- 2749US2011245529A1Method for producing optically active vinylcyclopropanecarboxylic acid derivative and optically active vinylcyclopropaneamino acid derivativeKANEKA CORP·Filed 2009·Application pending·0 cites
- 2847US2021062053A1Adhesive sheet for skin patchKANEKA CORP·Filed 2019·Application pending·0 cites
- 2947US2005014818A1Process for producing optically active chroman derivative and intermediateFiled 2002·Application pending·0 cites
- 3046US2020078347A1Therapeutic agent for onychomycosisKANEKA CORP·Filed 2017·Application pending·0 cites
- 3145US10525014B2PatchKANEKA CORP·Filed 2016·Granted Jan 7, 2020·0 cites·13 claims
- 3245US7582781B2Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the sameKANEKA CORP·Filed 2004·Granted Sep 1, 2009·0 cites·9 claims
- 3345US5556857ADisturbance-of-consciousness improving agentOTSUKA PHARMA CO LTD·Filed 1993·Granted Sep 17, 1996·10 cites·19 claims
- 3441US5017724AHydrofluorene derivativesOTSUKA PHARMA CO LTD·Filed 1990·Granted May 21, 1991·2 cites·11 claims
- 3540US5656633ACarbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonistOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 12, 1997·3 cites·13 claims
- 3640US2009275779A1Method for producing optically active benzylamine derivativeTANAKA TATSUYOSHI·Filed 2006·Application pending·0 cites
- 3736US2006167282A1Process for industrially producing optically active 1,4- benzodioxane derivativeTANAKA TATSUYOSHI·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tatsuyoshi Tanaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →